Phase 2 placebo-controlled RCT of 63 adults having single-level posterior lumbar interbody fusion: all had adverse events (mostly mild to moderate) with no drug-related serious events on bezeotermin alfa; fusion, ODI and VAS showed only a trend in favour.
RCTn = 63
Li et al. Bezeotermin Alfa (rhBMP-6) Administration in Lumbar Interbody Fusion Surgery Using a Posterior Approach: A Randomized, Double-Blinded, Placebo-Controlled Phase-2 Study